Skip to Content
Market Update

Earnings on Tap: Abbott, Apollo Group, U.S. Bancorp

Abbott shares are trading in 5-star territory ahead of its quarterly earnings announcement.

Mentioned: , ,

Drug and medical-device company  Abbott Laboratories (ABT) is slated to report quarterly earnings before the bell Wednesday. Analysts on average expect the firm to post earnings of $1.17 per share, compared with $1.05 (excluding one-time charges) in the year-ago quarter.

Analysts and shareholders will be interested to learn whether sales for its stent products picked up following the exit of  Johnson & Johnson (JNJ) from the business. Sales of the firm's blockbuster drug Humira will also be in focus.

Nazim Khan does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.